BCT-100: Clinical Trials

5 trials of BCT-100, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 terminated. 5 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 4, Terminated 1
Phase 22Completed 2

Follow BCT-100: new trials by email Literature Review of BCT-100 trials Research Report on BCT-100

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100)
PEG- BCT-100 - Cancer, Pediatric Solid Tumor
Phase 1 / Phase 2CompletedUniversity of Birmingham492018-08-282022-09-02
Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors
PEG-BCT-100 - Melanoma, Prostate Adenocarcinoma
Phase 1CompletedBio-Cancer Treatment International Limited232014-11-012020-04-24
A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or Lymphoma
Recombinant human arginase 1 Peg5000 - Leukemia, Lymphoma
Phase 1TerminatedBio-Cancer Treatment International Limited12012-04-012017-07-31
Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002)
Pegylated Recombinant Human Arginase I - Neoplasm, Hepatocellular Carcinoma
Phase 1 / Phase 2CompletedBio-Cancer Treatment International Limited202010-03-012012-03-14
Study of Pegylated Human Recombinant Arginase for Liver Cancer
Pegylated Recombinant Human Arginase I, Doxorubicin - Neoplasm, Hepatocellular Carcinoma
Phase 1CompletedBio-Cancer Treatment International Limited152008-05-012012-03-14

Conditions studied

Neoplasms (3)  ·  Carcinoma, Hepatocellular (2)  ·  Leukemia (1)  ·  Lymphoma (1)  ·  Melanoma (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Sponsors

Bio-Cancer Treatment International Limited (4)  ·  University of Birmingham (1)

Countries

Hong Kong (2)  ·  Australia (1)  ·  China (1)  ·  Netherlands (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Ronnie TP Poon, Prof (2)  ·  Alan K Chiang, Dr. (1)  ·  Alberto Bessudo, MD (1)  ·  Francis J Mussai, DPhil (1)  ·  Steven O'Day, MD (1)

Results publications

PMID 29776373, PMID 33856599, PMID 38357205